<VariationArchive VariationID="976481" VariationName="NM_003106.4(SOX2):c.87_96dup (p.Asn33fs)" VariationType="Duplication" Accession="VCV000976481" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2020-08-17" MostRecentSubmission="2020-08-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="964117" VariationID="976481">
      <GeneList>
        <Gene Symbol="LOC108281177" FullName="SOX2 5' regulatory region" GeneID="108281177" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181707848" stop="181712914" display_start="181707848" display_stop="181712914" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SOX2" FullName="SRY-box transcription factor 2" GeneID="6657" HGNC_ID="HGNC:11195" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181711925" stop="181714436" display_start="181711925" display_stop="181714436" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181429711" stop="181432223" display_start="181429711" display_stop="181432223" Strand="+" />
          </Location>
          <OMIM>184429</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SOX2-OT" FullName="SOX2 overlapping transcript" GeneID="347689" HGNC_ID="HGNC:20209" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181056680" stop="181742228" display_start="181056680" display_stop="181742228" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181328150" stop="181459008" display_start="181328150" display_stop="181459008" Strand="+" />
          </Location>
          <OMIM>616338</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003106.4(SOX2):c.87_96dup (p.Asn33fs)</Name>
      <CanonicalSPDI>NC_000003.12:181712439:CGGCGGCGGCCGGCGGC:CGGCGGCGGCCGGCGGCGGCCGGCGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q26.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181712439" stop="181712440" display_start="181712439" display_stop="181712440" variantLength="10" positionVCF="181712439" referenceAlleleVCF="G" alternateAlleleVCF="GCGGCGGCGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181430227" stop="181430228" display_start="181430227" display_stop="181430228" variantLength="10" positionVCF="181430227" referenceAlleleVCF="G" alternateAlleleVCF="GCGGCGGCGGC" />
      </Location>
      <ProteinChange>N33fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.181430235_181430244dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.181430235_181430244dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.181712447_181712456dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.181712447_181712456dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009080.1" sequenceAccession="NG_009080" sequenceVersion="1" change="g.5514_5523dup">
            <Expression>NG_009080.1:g.5514_5523dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003106.4" sequenceAccession="NM_003106" sequenceVersion="4" change="c.87_96dup" MANESelect="true">
            <Expression>NM_003106.4:c.87_96dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003097.1" sequenceAccession="NP_003097" sequenceVersion="1" change="p.Asn33fs">
            <Expression>NP_003097.1:p.Asn33fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_719" sequenceAccession="LRG_719">
            <Expression>LRG_719:g.5514_5523dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_719t1" sequenceAccession="LRG_719t1">
            <Expression>LRG_719t1:c.87_96dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1714839412" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003106.4(SOX2):c.87_96dup (p.Asn33fs) AND Anophthalmia/microphthalmia-esophageal atresia syndrome" Accession="RCV001253803" Version="2">
        <ClassifiedConditionList TraitSetID="3485">
          <ClassifiedCondition DB="MedGen" ID="C1859773">Anophthalmia/microphthalmia-esophageal atresia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-02-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-02-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-08-17" MostRecentSubmission="2020-08-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3485" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5530" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Anophthalmia/microphthalmia-esophageal atresia syndrome</ElementValue>
                <XRef ID="MONDO:0008799" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microphthalmia syndromic 3</ElementValue>
                <XRef ID="Microphthalmia+syndromic+3/4787" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microphthalmia and esophageal atresia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia clinical with associated anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia esophageal genital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AEG syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia microphthalmia esophageal atresia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MCOPS3</ElementValue>
                <XRef Type="MIM" ID="206900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 Disorder</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SOX2 disorder includes anophthalmia and/or microphthalmia, brain malformations, developmental delayÂ / intellectual disability, esophageal atresia, hypogonadotropic hypogonadism (manifest as cryptorchidism and micropenis in males, gonadal dysgenesis infrequently in females, and delayed puberty in both sexes), pituitary hypoplasia, postnatal growth delay, hypotonia, seizures, and spastic or dystonic movements.</Attribute>
                <XRef ID="NBK1300" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 anophthalmia syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-related eye disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-Related Eye Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1443" />
                <XRef ID="1443" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301477</ID>
                <ID Source="BookShelf">NBK1300</ID>
              </Citation>
              <XRef ID="77298" DB="Orphanet" />
              <XRef ID="C1859773" DB="MedGen" />
              <XRef ID="MONDO:0008799" DB="MONDO" />
              <XRef Type="MIM" ID="206900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2820876" SubmissionDate="2020-08-07" DateLastUpdated="2020-08-17" DateCreated="2020-08-17">
        <ClinVarSubmissionID localKey="SUB7897827" submittedAssembly="GRCh37" title="SUB7897827" />
        <ClinVarAccession Accession="SCV001427027" DateUpdated="2020-08-17" DateCreated="2020-08-17" Type="SCV" Version="1" SubmitterName="Clinical Genomics Laboratory, Stanford Medicine" OrgID="507411" OrganizationCategory="laboratory" OrgAbbreviation="CGP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Asn33Glyfs*66 variant in the SOX2 gene was identified de novo in this individual and has been previously reported as de novo in a 28 weeks gestation fetus with bilateral anophthalmia (Chassaing et al., 2014). This variant results in a 10bp duplication, which causes a shift in the protein reading frame leading to a premature termination codon 66 amino acids downstream. Although nonsense-mediated decay is not predicted to occur, the truncated protein is expected to result in loss-of-function. Heterozygous loss-of-function is an established mechanism of disease for the SOX2 gene. This variant was absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). However, the ability to detect large insertion/deletion variants is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, there is sufficient evidence to classify the p.Asn33Glyfs*66 variant as pathogenic for autosomal dominant SOX2-related eye disorders based on the information above. [ACMG evidence codes used: PVS1, PS2, PM2]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2">
              <Name>SRY-box transcription factor 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Asn33Glyfs*66</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.2:c.87_96dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="206900" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7897827</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2820876" TraitType="Disease" MappingType="XRef" MappingValue="206900" MappingRef="OMIM">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

